简介：Nanotechnologyprovidesvariousnanomaterialswithtremendousfunctionalitiesforcancerdiagnosticsandtherapeutics.Recently,theranosticshasbeendevelopedasanalternativestrategyforefficientcancertreatmentthroughcombinationofimagingdiagnosisandtherapeuticinterventionsundertheguidanceofdiagnosticresults.Ultrasound(US)imagingshowsuniqueadvantageswithexcellentfeaturesofreal-timeimaging,lowcost,highsafetyandportability,makingUScontrastagents(UCAs)anidealplatformforconstructionofcancertheranosticagents.ThisreviewfocusesonthedevelopmentofnanomaterialsincorporatedmultifunctionalUCAsservingastheranosticagentsforcancerdiagnosticsandtherapeutics,viaconjugationofsuperparamagneticironoxidenanoparticles(SPIOs),CuSnanoparticles,DNA,siRNA,goldnanoparticles(GNPs),goldnanorods(GNRs),goldnanoshell(GNS),grapheneoxides(GOs),polypyrrole(PPy)nanocapsules,Prussianblue(PB)nanoparticlesandsoontodifferenttypesofUCAs.Thecancertreatmentcouldbemoreeffectivelyandaccuratelycarriedoutundertheguidanceandmonitoringwiththehelpoftheachievedtheranosticagents.Furthermore,nanomaterialsincorporatedtheranosticagentsbasedonUCAscanbedesignedandconstructedbydemandforpersonalizedandaccuratetreatmentofcancer,demonstratingtheirgreatpotentialtoaddressthechallengesofcancerheterogeneityandadaptation,whichcanprovidealternativestrategiesforcancerdiagnosisandtherapeutics.

简介：Objective:Toevaluatethesafetyandefficacyofexternalhigh-intensityfocusedultrasound(HIFU)castrationforbreastcancerouspatientsaftermastectomyiftheyareatahighriskofrecurrence.Methods:Werecruited52consecutivepatientswithprimaryoperablebreastcancerwhoweretreatedwithmastectomywithexcisionofregionallymphnodes.PatientswerepositiveforERandPRimmuno-cytochemicalstaining,node-positive,un-menopause,over40yearsoldandweredividedintotwogroupsrandomly.Forcastration,26patientsreceivedoneortwotimesofHIFUtreatmentwithinfivedays,andtheotherpatientsreceivedradiotherapywithDT18Gy/9f/11days.Duringandafterthetreatment,localchangesandsystemicresponseofthepatientswereobserved.Results:After1monthtreatment,levelsofserumE1andE2weresignificantlydecreasedcomparedtobeforetreatmentinHIFUgroups(P<0.01andP<0.001).Thesamechangeswereoccurredinradiotherapy(RT)groups(P<0.05andP<0.01).ThelevelsofserumE1orE2inRTgroupswerehigherthaninHIFUgroups(P<0.05).Thesymptomdistributionof'climactericsyndrome'ofHIFUgroupsweresignificantlydifferentfromRTgroups(P<0.01).Thefollow-uptimewas4months.Theincidenceofamenorrheawas100%inallpatients.Noseriouscomplicationswereseen.Thetemperature,pulse,bloodpressure,andrespiratoryrateofthepatientswerealmostnormal.Conclusion:WehaveshownthattheuseofHIFUinthecastratingofpatientswithbreastcancerisfeasible,safeandeffective.ThistechnologymayprovidearapidnoninvasivealterativetoconventionalbilateraloophorectomyorRTcastration.

简介：Preoperativestagingoftheaxillainwomenwithinvasivebreastcancerusingultrasound-guidedneedlebiopsy(UNB)identifiesapproximately50%ofpatientswithaxillarynodalmetastasespriortosurgicalintervention.Althoughmoderatelysensitive,itisahighlyspecificstagingstrategythatisrarelyfalsely-positive,henceapositiveUNBallowspatientstobetriagedtoaxillarylymph-nodedissection(ALND)avoidingpotentiallyunnecessarysentinelnodebiopsy(SNB).Inthisreview,weextendourpreviousworkthroughanupdatedliteraturesearch,focusingonstudiesthatreportdataonUNButility.Basedondatafor10,934breastcancerpatients,sourcedfrom35studies,apositiveUNBallowedtriageof1,745cases(simpleproportion16%)toaxillarysurgicaltreatment:theutilityofUNBwasamedian19.8%[interquartilerange(IQR)11.6%-26.7%]acrossthesestudies.Wealsomodelleddatafromasubgroupofstudies,andestimatedthatamongstpatientswithmetastasestoaxillarynodes,theoddsratio(OR)forhighnodaldiseaseburdenforapositiveUNBversusanegativeUNBwas4.38[95%confidenceinterval(95%CI):3.13,6.13],P<0.001.Fromthismodel,theestimatedproportionwithhighnodaldiseaseburdenwas58.9%(95%CI:50.2%,67.0%)forapositiveUNB,whereastheestimatedproportionwithhighnodaldiseaseburdenwas24.6%(95%CI:17.7%,33.2%)ifUNBwasnegative.Overall,axillaryUNBhasgoodclinicalutilityandapositiveUNBcaneffectivelytriagetoALND.However,theevolvinglandscapeofaxillarysurgicaltreatmentmeansthatUNBwillhaverelativelylessutilitywheresurgeonshavemodifiedtheirpracticetoomissionofALNDforminimalnodalmetastaticdisease.

简介：